Patent ID: 8481597

Claim:
A method of lowering plasma uric acid levels and plasma glucose levels in a mammal, comprising administering to said mammal a therapeutically effective amount of a (−) stereoisomer of a compound selected from the group consisting of 2-acetamidoethyl 4-chlorophenyl-(3-trifluoromethylphenoxy) acetate, 4-chlorophenyl-(3-trifluoromethylphenoxy) acetic acid, or a pharmaceutically acceptable salt of 2-acetamidoethyl 4-chlorophenyl-(3-trifluoromethylphenoxy) acetate or 4-chlorophenyl-(3-trifluoromethylphenoxy) acetic acid; wherein the (−) stereoisomer of the compound is substantially free of the (+) stereoisomer of the compound.